Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
ABT MDT SYK ISRG Conservative Market Drivers Compulsion Insurance 
United States  USA  |  Investing Opportunities


Processing
Collecting data for SYK

Stryker quote and profile

 
 Companies |  Insiders  | Dashboard  
     
68.9
  
STOCK
(0.16)  Macroaxis: -0.23 Down   0.23%  
Year To Date
49.4369.81
Trading Day 
68.2868.97
May 19 2013 

Diversification Suggestion

Use Stryker to protect against small markets fluctuations. The stock experiences normal downward trend and little activity
Analyze Stryker Trend or Check current 30 days Stryker correlation with market (S&P 500)
1 Month Beta 0.63  
Highest Price:  
Lowest Price:  
69.43  
64.15  
May 15 2013 
April 22 2013 
As returns on market increase, Stryker returns are expected to increase less than the market. However during bear market, the loss on holding Stryker will be expected to be smaller as well.
Stryker Corporation Small BetaStryker Beta Legend
SYK United States NYSE
Stryker Corporation
Healthcare
Medical Appliances and Equipment
http://www.strykercorp.com
Contact Number: 269. 385. 2600
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation22.09 B
Shares Outstanding380.51 M
Number of Shares Shorted9.07 M
Revenue8.66 B
 United States Russel   1.11 % Macroaxis: change 1.11 Moved Up  
 
 United States SP 500   1.03 % Macroaxis: change 1.03 Moved Up  
 
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States NYSE   0.92 % Macroaxis: 0.92 Moved Up  
 
 thisRed SYK SYK agains markets  0.23 % Macroaxis: 0.23 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Stryker Leadership

Curt Hartman Interim CEO, CFO and VP
Kevin Lobo CEO and President and Director
William Parfet Non-Executive Chairman and Member of Governance and Nominating Committee
Steven Benscoter Vice President - Human Resources

Stryker Price and Market Media

The median price of Stryker for the period between Fri, Apr 19, 2013 and Sun, May 19, 2013 is 66.28 with a coefficient of variation of 2.53. The daily time series for the period is distributed with a sample standard deviation of 1.68, arithmetic mean of 66.54, and mean deviation of 1.39. The Stock received substential amount of media coverage during this period.
Stryker         Market
Price Growth (%)
 
1
Research and Markets Taiwan Endoscopy Devices Market Outlook...04/23/2013Macroaxis: News
2
Stryker Corp. reports 13 percent drop in profits due to prod...04/25/2013Macroaxis: News
3
Stryker Corporation Johnson and Johnson Earnings Pain Intens...04/29/2013Macroaxis: News
4
Research and Markets Stryker Corporation Product Pipeline An...05/01/2013Macroaxis: News
5
STRYKER CORPORATION Stryker to Present at Investor Conferenc...05/08/2013Macroaxis: News

Stryker Summary

Stryker Corporation [SYK] is traded on New York Stock Exchange in USA. It is located in Kalamazoo, MI and employs 22,010 people. The company currently falls under 'Large-Cap' category with total capitalization of 24.61 B. Stryker Corporation runs under Healthcare sector within Medical Appliances and Equipment industry. This company has 380.51 M outstanding shares of which 9.07 M shares are at this time shorted by investors with about 4.4 days to cover shorted positions.
Stryker Corporationration, a medical technology company, offer reconstructive, medical and surgical, and neurotechnology and spine solutions for doctors, hospitals, and other healthcare facilities. more
Past Market
Over 30
Days
22
Out Of
100
 
Chance of
Less
Than
%
 
Follow Stryker with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Stryker to your reader
 

Stryker Research Report

Stryker vs. Abbott

Correlation analysis and fundamentals comparison between Stryker and Abbott Laboratories

Stryker Executives

Dean Bergy Interim CFO, VP and Secretary

Stryker Directors

Roch Doliveux Independent Director
Howard Cox Independent Director
Allan Golston Independent Director
Ronda Stryker Independent Director
Howard Lance Independent Director

Stryker Fundamentals

Current Valuation vs Working Capital
Price to Sales vs Debt to Equity
Current Valuation vs Number of Employees
Current Ratio vs Debt to Equity

Stryker vs Competition

Stryker vs. Abbott Laboratories
Stryker vs. Medtronic Inc
Stryker vs. Intuitive Surgical Inc
Stryker vs. Zimmer Holdings Inc
Stryker vs. Boston Scientific Corporation
Stryker vs. St Jude Medical Inc
Stryker vs. Smith Nephew plc
Stryker vs. Edwards Lifesciences Corp
Stryker vs. Varian Medical Systems Inc

Stryker May 19 2013 Opportunity Range

Downside Deviation0.5474
Information Ratio(0.04)
Maximum Drawdown2.32
Value At Risk(0.82)
Potential Upside1.41

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium